Sage Journals: Discover world-class research

Abstract

BACKGROUND:

IVD degeneration is a widespread problem all over the world, which a variety of inflammatory cytokines have been implicated in, while Sphingosine 1-phosphate (S1P) is an important lipid mediator that may play a role in IVD degeneration.

OBJECTIVE:

To study the expression and role of S1PRs in the intervertebal disc (IVD) degeneration to enhance understanding of disc degeneration.

METHODS:

Degenerated and normal IVD were harvested from patients through surgery. Expression of S1P receptor subtypes was evaluated using real-time PCR, immunohistochemistry, and western blotting. The effect of S1PR on inflammation induced by interleukin-1 $\beta$ in nucleus pulposus (NP) cells was also assessed by real time PCR and western blotting.

RESULTS:

The nucleus pulposus mainly expressed the S1PR1/2/3, and the expression decreased in the severe degenerated nucleus pulposus cells. The ligand, S1P, inhibited the up-regulation of matrix metallopeptidase-3 (MMP-3) and ADAM metallopeptidase with thrombospondin type 1 motif 4 (ADAMTS4) induced by IL-1 $\beta$ .

CONCLUSIONS:

The results show that an the expression of S1PRs in degenerative discs is down-regulated as degeneration, and S1P can inhibit the inflammation response induced by IL-1 $\beta$ in NP cells, implicating that S1P/S1PR may contribute to IVD degeneration.

Keywords

Sphingosine 1-phosphate receptors nucleus pulposus cells intervertebral disc degeneration IL-1β

Get full access to this article

View all access options for this article.

References

McBeth

and Jones

. 2007. Epidemiology of chronic musculoskeletal pain. Best Practice & Research. Clinical Rheumatology 21, 403-25.

Goode

Carey

and Jordan

. 2013. Low back pain and lumbar spine osteoarthritis: how are they related? Current Rheumatology Reports 15, 305.

Livshits

Popham

Malkin

Sambrook

Macgregor

Spector

and Williams

. 2011. Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine Study. Annals of the Rheumatic Diseases 70, 1740-5.

Anderson

and Tannoury

. 2005. Molecular pathogenic factors in symptomatic disc degeneration. The Spine Journal: Official Journal of the North American Spine Society 5, 260s-6s.

Le Maitre

Pockert

Buttle

Freemont

and Hoyland

. 2007. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochemical Society Transactions 35, 652-5.

Hartman

Yurube

Jacobs

Sowa

and Kang

. 2013. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. The Spine Journal: Official Journal of the North American Spine Society 13, 331-41.

Phillips

Cullen

Chiverton

Michael

Cole

Breakwell

Haddock

Bunning

Cross

and Le Maitre

. 2015. Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes. Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 23, 1165-77.

Seguin

Pilliar

Roughley

and Kandel

. 2005. Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine (Phila Pa 1976) 30, 1940-8.

Le Maitre

Hoyland

and Freemont

. 2007. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Research & Therapy 9, R77.

10.

Yang

Chang

Liu

Han

Zhu

Yang

and Li

. 2012. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-beta1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis. The American Journal of Pathology 181, 85-97.

11.

Masuko

Murata

Beppu

Nakamura

Kato

and Yudoh

. 2012. Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis. International Journal of Rheumatic Diseases 15, 366-73.

12.

Ogawa

Takahashi

Hirose

Morimoto

Ise

Murakami

Yasue

Kuriyama

Hongo

Kobayashi

and Ikeda

. 2007. A novel sphingosine-1-phosphate receptor agonist KRP-203 attenuates rat autoimmune myocarditis. Biochemical and Biophysical Research Communications 361, 621-8.

13.

Stradner

Gruber

Angerer

Huber

Setznagl

Kremser

Moazedi-Furst

Windhager

and Graninger

. 2013. Sphingosine 1-phosphate counteracts the effects of interleukin-1beta in human chondrocytes. Arthritis and Rheumatism 65, 2113-22.

14.

Moon

Jeong

Lee

Seol

and Park

. 2012. Sphingosine-1-phosphate inhibits interleukin-1beta-induced inflammation in human articular chondrocytes. International Journal of Molecular Medicine 30, 1451-8.

15.

Rutges

Duit

Kummer

Bekkers

Oner

Castelein

Dhert

and Creemers

. 2013. A validated new histological classification for intervertebral disc degeneration. Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 21, 2039-47.

16.

Cyster

and Schwab

. 2012. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annual Review of Immunology 30, 69-94.

17.

Coste

Brenneis

Linke

Pierre

Maeurer

Becker

Schmidt

Gao

Geisslinger

and Scholich

. 2008. Sphingosine 1-phosphate modulates spinal nociceptive processing. The Journal of Biological Chemistry 283, 32442-51.

18.

David

Ciurea

Iencean

and Mohan

. 2010. Angiogenesis in the degeneration of the lumbar intervertebral disc. Journal of Medicine and Life 3, 154-61.

19.

Risbud

and Shapiro

. 2014. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nature Reviews. Rheumatology 10, 44-56.

20.

Iida

Akeda

Kasai

Masuda

Morimoto

Sakakibara

Sato

and Uchida

. 2009. Expression of proteinase-activated receptor-2 in the intervertebral disc. Spine (Phila Pa 1976) 34, 470-8.

21.

Tsai

Lai

Liao

Niu

Chen

Lee

Chen

Fang

and Pang

. 2013. Increased periostin gene expression in degenerative intervertebral disc cells. The Spine Journal: Official Journal of the North American Spine Society 13, 289-98.

22.